摘要
目的 :探讨腹腔镜联合康妇炎胶囊治疗盆腔粘连合并慢性盆腔痛的治疗效果。方法 :选取2014年6月-2016年6月于我院治疗的102例盆腔粘连合并慢性盆腔痛患者为研究对象,按随机数字表法分为联合组与对照组,各51例。两组患者均采用腹腔镜下分离术对盆腔粘连部位进行镜下分离操作,联合组术后即给予康妇炎胶囊(3粒,tid,po),比较两组临床疗效、临床症状改善情况及不良反应情况。结果 :联合组第3,6,12个月的总体显效率高于对照组(P<0.05);联合组术后出现腹痛、盆腔积液及子宫附件压痛症状的发生率均低于对照组(P<0.05);两组治疗后均无明显不良反应发生。结论 :腹腔镜联合康妇炎胶囊治疗盆腔粘连合并慢性盆腔痛的效果显著,值得临床推广使用。
Objective:To investigate the efficacy of laparoscopy combined with kangfuyan capsule in treating pelvic adhesion with chronic pelvic pain. Methods:102 cases of pelvic adhesion with chronic pelvic pain patients admitted to our hospital from June 2014 to June 2016 were selected as subjects and randomly divided into combined group and control group, 51 cases in each group. The patients in both group were treated with laparoscopic separation of the pelvic adhesion sites, and the combined group were given kangfuyan capsule after the surgery. The clinical efficacy, improvement of clinical symptoms and adverse reactions were compared between two groups. Results:The overall marked effective rate of the combined group was higher than that of the control group at the 3 rd month, the 6 th month and the 12 th month(P<0.05); the incidence of abdominal pain, pelvic effusion, and uterine attachment tenderness were lower in the combined group than those in the control group(P<0.05). No obvious adverse reactions occurred after treatment in both groups. Conclusion:Laparoscopy combined with kangfuyan capsule in the treatment of pelvic adhesions with chronic pelvic pain is effective, which is worthy of clinical application.
出处
《中国执业药师》
CAS
2018年第5期75-77,共3页
China Licensed Pharmacist
关键词
盆腔粘连
慢性盆腔痛
康妇炎胶囊
疗效
Pelvic Adhesions
Chronic Pelvic Pain
Kangfuyan Capsule
Efficacy
